RESPECTED TV PERSONALITY REVEALS HER EYE CONCERNS AND HER SUFFERING FROM DRY EYE DISEASE

Dec 6

Dry eye disease (DED) affects more than 4 million Australian people and yet only 26% have visited an optometrist to discuss treatment options. Accomplished and awarded journalist, Melissa Doyle, known for her longstanding positions co-hosting the Seven Network’s Sunrise and Sunday Night programs, and as the weekend breakfast host for radio station Smooth FM, is one of the 4 million Australian’s who suffers Dry eye disease.

For more than 10 years, Melissa has been suffering sore, red, watery, and puffy eyes, not knowing until recently that her symptoms were a serious chronic, and progressive eye condition. “I was always told the problem was likely allergies, so have endured just about every allergy test under the sun, however after a recent visit and testing with Dr Jim Kokkinakis at the Eye Practice in Sydney, I have now been diagnosed with Dry eye disease due to ocular rosacea” – Melissa Doyle, OptiLight Ambassador.

“In my clinic we deal with dry eye disease every day and have found that in order to make a meaningful impact on the disease, we need to address the underlying inflammation. Lumenis’ OPT technology helps us to address inflammation” - Dr. Jason Holland, Lead Clinical Optometrist at The Eye Health Centre in QLD.

OptiLight by Lumenis is the first and only FDA approved and TGA listed IPL technology with patented Optimal Pulse Technology (OPT®) to treat Dry eye disease (https://lumenis.com.au/medical/eye-care-products/optilight/).

OptiLight uses Intense Pulsed Light to break the vicious cycle of DED by alleviating abnormal blood vessels and rosacea, restoring Meibomian glands, and tear osmolarity levels, improving tear break-up time, reducing inflammatory mediators and decreasing demodex mites and bacterial burden.

OptiLight treatments take around 15 minutes, with the recommend treatment plan taking place over four consecutive sessions - making OptiLight treatments an easy appointment to slot into the patients’ busy days. Ground-breaking products, like OptiLight, continue to define Lumenis as a global leader and expert in the field of minimally invasive and non-invasive clinical solutions.

“Lumenis has launched many ‘firsts’ in eye care, because we never stop innovating” - Lumenis Country Manager, Richard New. Should you require commentary on Dry eye disease, Clinical and product development or first-person experience and insight, the following individuals are available for an interview/Q&A:

Melissa Doyle – OptiLight Ambassador

https://www.instagram.com/melissadoyleofficial/

Dr Jim Kokkinakis – Sydney based Optometrist and Authority on Dry Eye

https://www.theeyepractice.com.au/jim-kokkinakis/

Dr Jason Holland – Brisbane based Clinical Optometrist – The Eye Health Centre

https://theeyehealthcentre.com.au/meet-the-team/#clinical-optometrists

Dr John Hogden – Brisbane based Ophthalmologist – The Eye Health Centre

https://theeyehealthcentre.com.au/meet-the-team/#clinical-optometrists

Dr Rolando Toyos MD – Toyos Clinic in Memphis and inventor of IPL Treatment for Dry Eye Disease

https://toyosclinic.com/staff-feed/dr-rolando-toyos-md

Richard New – Lumenis Country Manager ANZ

Please see the relevant press release information here.